标题 |
A Phase II Clinical Study on Apatinib Plus Vinorelbine in Refractory HER2-Negative Breast Cancer and its Metabolic Implications of Drug Resistance
阿帕替尼联合长春瑞滨治疗难治性HER2阴性乳腺癌的II期临床研究及其耐药的代谢意义
|
网址 | |
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
求助人 | |
下载 |